TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Nordic Nanovector ASA ( (DE:8NN) ) has shared an announcement.
Thor Medical ASA has announced the appointment of Therese Kvehaugen as Executive Vice President of Human Resources and Mathias Nilsen Reierth as Head of Communications and Corporate Affairs. These strategic additions to the executive management team are aimed at supporting the company’s growth into a global leader in the sustainable supply of alpha isotopes for targeted cancer therapies. The new hires bring extensive experience in HR and strategic communications, which is expected to aid Thor Medical’s transition from a pioneering phase to an industrial-scale supplier in the targeted cancer therapies market.
More about Nordic Nanovector ASA
Thor Medical ASA is an emerging supplier of radionuclides, primarily focusing on alpha particle emitters derived from naturally occurring thorium. The company employs a proprietary production process that avoids irradiation or nuclear reactors, ensuring a reliable, environmentally friendly, and cost-efficient supply of alpha-emitters for the radiopharmaceutical industry. Headquartered in Oslo, Norway, Thor Medical is listed on the Oslo Stock Exchange under the ticker symbol ‘TRMED’.
Average Trading Volume: 3,360,740
Current Market Cap: NOK1.27B
For an in-depth examination of 8NN stock, go to TipRanks’ Overview page.